Community outcomes: Hyperfractionated radiotherapy with concurrent cisplatin and locally-advanced head and neck cancer

被引:0
|
作者
Maguire, PD [1 ]
机构
[1] New Hanover Reg Med Ctr, Wilmington, NC USA
来源
CANCER JOURNAL | 2002年 / 8卷 / 06期
关键词
D O I
10.1097/00130404-200211000-00065
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
P20
引用
收藏
页码:500 / 501
页数:2
相关论文
共 50 条
  • [1] Hyperfractionated radiotherapy with concurrent docetaxel in locally-advanced head and neck cancer
    Karasawa, K.
    Izawa, H.
    Hirowatari, H.
    Ito, K.
    Furuya, T.
    Ozawa, S.
    Matsumoto, F.
    Ito, S.
    Oba, S.
    Ikeda, K.
    [J]. EJC SUPPLEMENTS, 2009, 7 (02): : 480 - 480
  • [2] Hyperfractionated accelerated radiotherapy in combination with weekly cisplatin for locally advanced head and neck cancer
    Beckmann, GK
    Hoppe, F
    Pfreundner, L
    Flentje, MP
    [J]. HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK, 2005, 27 (01): : 36 - 43
  • [3] Concurrent hyperfractionated accelerated radiotherapy with 5-FU and once weekly cisplatin in locally advanced head and neck cancer
    Budach, V.
    Becker, E. -T.
    Boehmer, D.
    Badakhshi, H.
    Jahn, U.
    Wernecke, K. -D.
    Stromberger, C.
    [J]. STRAHLENTHERAPIE UND ONKOLOGIE, 2014, 190 (03) : 250 - 255
  • [4] Hyperfractionated radiotherapy with concurrent docetaxel for advanced head and neck cancer
    Karasawa, K.
    Ito, K.
    Takada, T.
    Matsumoto, F.
    Haruyama, T.
    Ito, S.
    Ikeda, K.
    [J]. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2006, 66 (03): : S450 - S451
  • [5] Induction chemotherapy followed by hyperfractionated radiotherapy with concurrent chemotherapy for locally advanced head and neck cancer
    Karasawa, K
    Shinoda, H
    Katsui, K
    Seki, K
    Kohno, M
    Hanyu, N
    Nasu, S
    Muramatsu, H
    Maebayashi, K
    Mitsuhashi, N
    Yoshihara, T
    [J]. ANTICANCER RESEARCH, 2003, 23 (6D) : 5031 - 5036
  • [6] Hyperfractionated radiotherapy versus hyperfractionated radiotherapy and concomitant chemotherapy in locally advanced head and neck cancer
    Kasibhatla, M.
    Prosnitz, L. R.
    Fisher, S. R.
    Scher, R. L.
    Clough, R.
    Brizel, D. M.
    [J]. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2007, 69 (03): : S11 - S12
  • [7] Concurrent cisplatin and radiotherapy in advanced head and neck cancer
    Rehan Asif
    Kamlesh Chandra
    Vanita Chopra
    M. L. B. Bhatt
    [J]. Indian Journal of Otolaryngology and Head and Neck Surgery, 2003, 55 (2): : 94 - 96
  • [8] Hyperfractionated radiation therapy and cisplatin for locally-advanced head and neck cancer (LAHNC). Experience of the Hospital de Navarra
    Arias, F.
    Dominguez, M. A.
    Villafranca, E.
    Romero, P.
    Manterola, A.
    Martinez, E.
    Oria, E.
    Asin, G.
    Rico, M.
    Arraras, J. I.
    [J]. EJC SUPPLEMENTS, 2007, 5 (04): : 333 - 333
  • [9] Concurrent weekly docetaxel and hyperfractionated radiotherapy for advanced head and neck cancer
    Matsumoto, Fumihiko
    Karasawa, Kumiko
    Itoh, Shin
    Toda, Megumi
    Haruyama, Takuo
    Furukawa, Masayuki
    Ikeda, Katsuhisa
    [J]. ANTICANCER RESEARCH, 2006, 26 (5B) : 3781 - 3786
  • [10] Accelerated hyperfractionated radiotherapy and concurrent protracted venous infusion chemotherapy in locally advanced head and neck cancer
    Arcangeli, G
    Saracino, B
    Danesi, DT
    de Campora, E
    Giovinazzo, G
    Cognetti, F
    Carlini, P
    Arcangeli, S
    Mecozzi, A
    [J]. AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 2002, 25 (05): : 431 - 437